Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 249

    1.

    Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU.

    Diabetes Care. 2006 Apr;29(4):853-7.PMID: 16567827 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU.

    Diabetes Care. 2007 May;30(5):1173-8. Epub 2007 Jan 26.PMID: 17259477 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?

    Axelsson J, Wang X, Ketteler M, Qureshi AR, Heimbürger O, Bárány P, Lindholm B, Nordfors L, Stenvinkel P.

    Am J Nephrol. 2008;28(4):669-76. Epub 2008 Mar 13.PMID: 18337634 [PubMed - indexed for MEDLINE]Related articles

    4.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.

    Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA.

    J Clin Endocrinol Metab. 2007 May;92(5):1886-90. Epub 2007 Feb 13.PMID: 17299074 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.

    Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA.

    Diabetes. 2004 May;53(5):1279-84. Erratum in: Diabetes. 2004 Sep;53(9):2518. Volarova de Courten, B [corrected to Vozarova de Courten, B]. PMID: 15111497 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM.

    Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG.

    Int J Obes Relat Metab Disord. 1995 Dec;19(12):846-50.PMID: 8963350 [PubMed - indexed for MEDLINE]Related articles

    8.

    Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

    Gastroenterology. 2008 Jul;135(1):122-30. Epub 2008 Mar 21.PMID: 18474251 [PubMed - indexed for MEDLINE]Related articles

    9.

    Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

    Stefan N, Stumvoll M, Bogardus C, Tataranni PA.

    Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1156-61. Epub 2003 Feb 11.PMID: 12582008 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.

    Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS.

    N Engl J Med. 2004 Jun 17;350(25):2549-57.PMID: 15201411 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat.

    Stefan N, Machicao F, Staiger H, Machann J, Schick F, Tschritter O, Spieth C, Weigert C, Fritsche A, Stumvoll M, Häring HU.

    Diabetologia. 2005 Nov;48(11):2282-91. Epub 2005 Oct 5.PMID: 16205883 [PubMed - indexed for MEDLINE]Related articles

    12.

    High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1884-8.PMID: 12031977 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    AHSG tag single nucleotide polymorphisms associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 white Danish subjects.

    Andersen G, Burgdorf KS, Sparsø T, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O.

    Diabetes. 2008 May;57(5):1427-32. Epub 2008 Mar 3.PMID: 18316360 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene.

    Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G.

    Diabetes. 2002 Aug;51(8):2450-8.PMID: 12145157 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes.

    Kalabay L, Cseh K, Pajor A, Baranyi E, Csákány GM, Melczer Z, Speer G, Kovács M, Siller G, Karádi I, Winkler G.

    Eur J Endocrinol. 2002 Aug;147(2):243-8.PMID: 12153747 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

    Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H.

    J Clin Endocrinol Metab. 2002 Jul;87(7):3023-8.PMID: 12107194 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

    Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.PMID: 17681171 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification and characterization of metabolically benign obesity in humans.

    Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU.

    Arch Intern Med. 2008 Aug 11;168(15):1609-16.PMID: 18695074 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes.

    Johanson EH, Jansson PA, Lönn L, Matsuzawa Y, Funahashi T, Taskinen MR, Smith U, Axelsen M.

    J Clin Endocrinol Metab. 2003 Sep;88(9):4232-8.PMID: 12970292 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data